Recombinant human interferon alpha-1b (Shanghai Institute of Biological Products)

N/A

Report date: 2022/01/24 10:09:34

Base Information

Drug NameRecombinant human interferon alpha-1b (Shanghai Institute of Biological Products)
Drug Alias NameShang Sheng Lei Tai重组人干扰素γRecombinant Human Interferon γRecombinant human interferon alpha-1b, Shanghai Institute of Biological Products上生雷泰
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsLeukemia, Hairy CellHepatitis B
Global Approved IndicationsLeukemia, Hairy CellHepatitis B
Approved Indications in ChinaLeukemia, Hairy CellHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Hairy CellHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB
Related LinksN/A